Human Papillomavirus (HPV)-Associated Squamous Cell Carcinoma In situ With Positive p16 and Ki-67 Immunohistochemical Stains in a Young Immunocompetent Patient

Autor: Aditi Chandra, Andrew Newman, Christine C Lin, Dustin Mullens

Publikováno v: Cureus

There is an oncogenic role of human papillomavirus (HPV) in the development of premalignant and malignant skin cancers, especially squamous cell carcinomas (SCCs). Some of the major risk factors for SCC include older age, fair skin types, immunosuppr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d004c719b96c5e0e6b6664ea2832fa5d
https://doi.org/10.7759/cureus.9673

Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation.

Autor: Lin TA; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., McCaw ZR; Insitro, South San Francisco, California.; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Koong A; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lin C; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Abi Jaoude J; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, Stanford Medicine, Palo Alto, California., Patel R; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, Memorial-Sloan Kettering Cancer Center, New York, New York., Kouzy R; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., El Alam MB; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sherry AD; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Noticewala SS; Division of Radiation Oncology, Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fuller CD; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Thomas CR Jr; Department of Radiation Oncology and Applied Sciences, Dartmouth Cancer Center, Geisel School of Medicine, Lebanon, New Hampshire., Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lin R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shyr Y; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Meirson T; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel., Ludmir EB; Division of Radiation Oncology, Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 15; Vol. 30 (20), pp. 4791-4799.

Predicting Primary Graft Dysfunction in Lung Transplantation: Machine Learning-Guided Biomarker Discovery.

Autor: Nord D; Division of Pulmonary Medicine, University of Florida, Gainesville, FL., Brunson JC; Laboratory for Systems Medicine, University of Florida, Gainesville, FL., Langerude L; Division of Pulmonary Medicine, University of Florida, Gainesville, FL., Moussa H; Division of Pulmonary Medicine, University of Florida, Gainesville, FL., Gill B; Division of Pulmonary Medicine, University of Florida, Gainesville, FL., Machuca T; Department of Surgery, University of Miami, Miami, FL., Rackauskas M; Department of Surgery, University of Florida, Gainesville, FL., Sharma A; Department of Surgery, University of Florida, Gainesville, FL., Lin C; Department of Medicine, University of California San Diego, San Diego, CA., Emtiazjoo A; Division of Pulmonary Medicine, University of Florida, Gainesville, FL., Atkinson C; Department of Surgery, Northwestern University, Chicago, IL.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 23. Date of Electronic Publication: 2024 Sep 23.

Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials.

Autor: Sherry AD; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Msaouel P; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kupferman GS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin TA; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD., Abi Jaoude J; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Kouzy R; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., El-Alam MB; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel R; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Koong A; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin C; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Passy AH; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Miller AM; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beck EJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fuller CD; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meirson T; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel., McCaw ZR; Insitro, South San Francisco, CA, USA.; Department of Biomedical Informatics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Ludmir EB; Department of Gastrointestinal Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Jul 24. Date of Electronic Publication: 2024 Jul 24.

Association of differential censoring with survival and suboptimal control arms among oncology clinical trials.

Autor: Hsu EJ; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Lin TA; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Dabush DR; Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel., McCaw Z; Department of Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Koong A; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin C; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abi Jaoude J; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel R; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kouzy R; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., El Alam MB; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Noticewala S; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang Y; School of Bioinformatics, University of Texas Health Science Center at Houston, Houston, TX, USA., Sherry AD; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fuller CD; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thomas CR Jr; Radiation Oncology, Dartmouth Cancer Center, Geisel School of Medicine, Lebanon, NH, USA., Tang C; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Msaouel P; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Das P; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang B; Pfizer Inc, Groton, CT, USA., Tian L; Department of Health Research and Policy, Stanford University, Stanford, CA, USA., Sun R; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee JJ; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meirson T; Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Ludmir EB; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Jun 07; Vol. 116 (6), pp. 990-994.